Pfizer 2013 Annual Report Download - page 39

Download and view the complete annual report

Please find page 39 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Financial Review
Pfizer Inc. and Subsidiary Companies
38
2013 Financial Report
The following table provides a reconciliation of Reported diluted EPS, as reported under U.S. GAAP, and Non-GAAP Adjusted diluted EPS:
Year Ended December 31, % Change
2013 2012 2011 13/12 12/11
Earnings per common share—diluted
GAAP Reported income from continuing operations attributable to Pfizer Inc.
common shareholders $ 1.65 $ 1.20 $ 0.99 38 21
Income from discontinued operations—net of tax 1.54 0.74 0.28 108 *
GAAP Reported net income attributable to Pfizer Inc. common shareholders 3.19 1.94 1.27 64 53
Purchase accounting adjustments—net of tax 0.46 0.47 0.63 (2) (25)
Acquisition-related costs—net of tax 0.06 0.10 0.18 (40) (44)
Discontinued operations—net of tax (1.54) (0.74) (0.28) (108) *
Certain significant items—net of tax 0.05 0.33 0.38 (85) (13)
Non-GAAP Adjusted income attributable to Pfizer Inc. common shareholders(a) $ 2.22 $ 2.10 $ 2.18 6(4)
(a) Reported and Adjusted diluted earnings per share in all periods presented were significantly impacted by the decrease in the number of shares outstanding,
due to the Company's ongoing share repurchase program and in 2013, the impact of the Zoetis exchange offer.
* Calculation not meaningful.
Certain amounts and percentages may reflect rounding adjustments.